CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.

Patrick N. Song; Chloe T. DeMellier; Shannon E. Lynch; Carlos A. Gallegos; Ameer Mansur; Jonathan A. Moye; Alessandro Mascioni; Fang Jia; Christopher D. Willey; Anna G. Sorace

doi:10.1186/s13058-026-02286-9

← 뒤로

CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.

Breast cancer research : BCR 2026 🔓 OA Cancer Immunotherapy and Biomarkers

OpenAlex 토픽 · Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Nanoplatforms for cancer theranostics

Song PN, DeMellier CT, Lynch SE, Gallegos CA, Mansur A, Moye JA, Mascioni A, Jia F, Willey CD, Sorace AG

🔓 OA 전문 ↗ 원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Patrick N. Song, Chloe T. DeMellier, et al. (2026). CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.. Breast cancer research : BCR. https://doi.org/10.1186/s13058-026-02286-9

MLA Patrick N. Song, et al.. "CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.." Breast cancer research : BCR, 2026.

PMID 42035192

DOI 10.1186/s13058-026-02286-9

같은 제1저자의 인용 많은 논문 (1)

Molecular imaging of tucatinib-induced cellular and TME changes in preclinical models of HER2 + breast cancer.
Breast cancer research and treatment 2026